Revance Bought Out by Crown Labs: What Does the Future Hold?
Crown Laboratories has announced a buyout of Revance Therapeutics for $924 million, marking a significant merger in the aesthetics and skincare industry. This deal involves
Crown Laboratories has announced a buyout of Revance Therapeutics for $924 million, marking a significant merger in the aesthetics and skincare industry. This deal involves
Why Should Plastic Surgeons Use Twitter? Recently, I was named in an Aesthetic Surgery Journal article as one of the “Top 100
Get all the latest news, exclusive deals, and official updates.